Search Results - "Kotzen, Elizabeth"

  • Showing 1 - 11 results of 11
Refine Results
  1. 1

    Rituximab as an immunosuppressant in antineutrophil cytoplasmic antibody-associated vasculitis by McGregor, JulieAnne G, Hogan, Susan L, Kotzen, Elizabeth S, Poulton, Caroline J, Hu, Yichun, Negrete-Lopez, Roberto, Kidd, Jason M, Katsanos, Suzanne L, Bunch, Donna O, Nachman, Patrick H, Falk, Ronald J

    Published in Nephrology, dialysis, transplantation (01-04-2015)
    “…Rituximab has been used in antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) since 2003. Our objective was to describe outcomes and…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Antiphospholipid Syndrome Nephropathy and Other Thrombotic Microangiopathies Among Patients With Systemic Lupus Erythematosus by Kotzen, Elizabeth S., Roy, Sanjeet, Jain, Koyal

    Published in Advances in chronic kidney disease (01-09-2019)
    “…Antiphospholipid syndrome (APS) and other causes of thrombotic microangiopathy (TMA) negatively impact the renal outcomes of patients with systemic lupus…”
    Get full text
    Journal Article
  4. 4

    Clinician Educator Pathway for Nephrology Fellows: The University of North Carolina Experience by Priamvada, Gargi S., Kotzen, Elizabeth S., Jain, Koyal

    Published in Advances in chronic kidney disease (01-11-2022)
    “…Nephrologists have a significant role in educating and mentoring trainees. They are considered role models and a major reason for fellows to be attracted to…”
    Get full text
    Journal Article
  5. 5
  6. 6
  7. 7
  8. 8

    Kidney thrombotic microangiopathy in lupus nephritis: Impact on treatment and prognosis by Massicotte-Azarniouch, David, Kotzen, Elizabeth, Todd, Sarah, Hu, Yichun, Hogan, Susan L., Jain, Koyal

    Published in Lupus (01-09-2022)
    “…Introduction Lupus nephritis (LN) may present with thrombotic microangiopathy (TMA) on kidney biopsy, the impact of which on outcomes is unclear. This study…”
    Get full text
    Journal Article
  9. 9

    Alemtuzumab versus anti‐thymocyte globulin in kidney transplant recipients receiving a rapid steroid withdrawal regimen by Rikard, Rachel A., Chargualaf, Laura M., Coulter, Carolyn, Weimer, Eric T., Schmitz, John L., Kotzen, Elizabeth S., Prom, Alyson, Toledo, Alexander H., Szempruch, Kristen R.

    Published in Clinical transplantation (01-02-2024)
    “…Introduction In kidney transplant recipients (KTRs), steroid‐free maintenance regimens are used to minimize the negative impact of steroid use. Studies…”
    Get full text
    Journal Article
  10. 10
  11. 11

    104 - Interstitial nephritis by Kotzen, Elizabeth S., Zeitler, Evan M., Hladik, Gerald A.

    Published in Textbook of Critical Care (2024)
    “…Acute interstitial nephritis (AIN) is the third most common cause of acute kidney disease in hospitalized patients, following prerenal azotemia and acute…”
    Get full text
    Book Chapter